semicarbazide

Semicarbazide hydrochloride is a urea derivative that binds to copper or iron in cells to produce antiviral, anti-infective and anti-tumor effects.

Semicarbazide-13C-15N2 Hydrochloride is the 13C and 15N labeled compound of Semicarbazide Hydrochloride. Semicarbazide Hydrochloride has a CAS number of 563-41-7. Semicarbazide is Snow white crystals and used as a reagent for ketones and aldehydes with which it affords crystalline compounds having characteristic melting points.

4-Cyclohexyl-1-phenylthiosemicarbazide is employed as an intermediate.

1-(3',6'-Bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)-3-phenylthiourea is a useful organic compound for research related to life sciences and the catalog number is T64845.

1-Phenylsemicarbazide is a useful organic compound for research related to life sciences. The catalog number is T67157 and the CAS number is 103-03-7.

Selenosemicarbazide (Hydrazinecarboselenoamide) exhibits antibacterial properties, effectively inhibiting B. subtilis, S. aureus, Klebsiella pneumoniae, Sarcina lutea, and Mycobacterium tuberculosis. Additionally, it forms complexes with metal ions, demonstrating antitumor activity against cancer cells.

Dibenzothiophene (Imino semicarbazide), a component of petroleum oils, is a sulfur-containing polycyclic aromatic hydrocarbon (PAH) derivate consisting of 3 fused rings with keratolytic activity.

Aminoguanidine hydrochloride (Hydrazinecarboximidamide) is a diamine oxidase and NO synthase inhibitor, used in the treatment of diabetic nephropathy.

BI-1467335 HCl(BI 1467335) is a selective, orally active inhibitor of semicarbazide-sensitive amine oxidase (SSAO) that helps improve chronic obstructive pulmonary disease in mice[2].

Pimagedine is a prototype therapeutic agent for the prevention of formation of advanced glycation endproducts. Pimagedine reacts rapidly with α,β-dicarbonyl compounds such as methylglyoxal, glyoxal, and 3-deoxyglucosone to prevent the formation of advanced glycation endproducts (AGEs).

PXS-4681A is a powerful, specific, and irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO; VAP-1), with an oral activity and a Ki value of 37 nM. It exhibits exceptional selectivity towards related amine oxidases, ion channels, and seven-transmembrane domain receptors. Additionally, PXS-4681A demonstrates potent anti-inflammatory properties.

2-Nitrobenzaldehyde Semicarbazone is a metabolite marker for the detection of Nitrofurazone, a highly restricted antibiotic. This compound, derived from Semicarbazide, exhibits significant potential in identifying the presence of Nitrofurazone.

SSAO inhibitor-1 is a compound that acts as an inhibitor of semicarbazide-sensitive amine oxidase (SSAO). It exhibits anti-inflammatory properties and is commonly employed in research pertaining to liver diseases.

2-Nitrobenzaldehyde semicarbazone (13C, 15N2) is utilized in the LC-MS/MS method for semicarbazide analysis.

SSAO inhibitor-2 (Compound 1) is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC50 values <10 nM for human SSAO and 10-100 μM for MAO-A, respectively [1]. It can be used in the research of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, and multiple sclerosis.

SSAO inhibitor-3 (Compound 2) is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC50 values of 0.1-10 μM and <10 nM for human AOC1 and SSAO, respectively, and can be used in the study of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, and multiple sclerosis, etc. [1].

MD 220661 is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO), and a substrate of the enzyme.